First-line sequential high-dose VIP chemotherapy with autologous transplantation for patients with primary mediastinal nonseminomatous germ cell tumours: A prospective trial

British Journal of Cancer

Volumn 89, Issue 1, 2003, Pages 29-35

  Bokemeyer, C ^a   Schleucher, N ^b   Metzner, B ^c   Thomas, M ^d   Rick, O ^e   Schmoll, H J ^f   Kollmannsberger, C ^a   Boehlke, I ^a   Kanz, L ^a   Hartmann, J T ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c KLINIKUM OLDENBURG   (Germany)

^d UNIVERSITY OF MÜNSTER   (Germany)

^e CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^f MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Autologous transplantation; Extragonadal germ cell tumours; High dose chemotherapy; Mediastinal primary; Nonseminomatous histology

Indexed keywords

CISPLATIN; ETOPOSIDE; IFOSFAMIDE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; ARTICLE; AUTOTRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; ENTERITIS; FEVER; FOLLOW UP; GERM CELL TUMOR; GRANULOCYTOPENIA; HUMAN; INFECTION; MEDIASTINUM TUMOR; MUCOSA INFLAMMATION; MULTICENTER STUDY; NEUROTOXICITY; NON SEMINOMATOUS GERMINOMA; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; THROMBOCYTOPENIA;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; ETOPOSIDE; FEMALE; GERMINOMA; GRANULOCYTE COLONY-STIMULATING FACTOR; HUMANS; IFOSFAMIDE; MALE; MEDIASTINAL NEOPLASMS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PROGNOSIS; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0042346023     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6600999     Document Type: Article

References (42)

1. Birch R, Williams S, Cone A, Einhorn L, Roark P, Turner S, Greco FA (1986) Prognostic factors for favorable outcome in disseminated germ cell tumors. J Clin Oncol 4: 400-407
2. Bokemeyer C, Harstrick A, Beyer J, Metzner B, Ruther U, Hartmann JT, Holstein K, Derigs HG, de Wit R, Casper J, Schoffski P, Kuhrer I, Illiger HJ, Kempf B, Reichle A, Foller A, Hossfeld DK, Fischer JT, Berdel WE, Gerhartz HH, Kirchner H, Pfluger KH, Ostermann H, Kanz L, Schmoll HJ (1998) The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous germ cell tumors. The German Testicular Cancer Study Group. Sem Oncol 25(Suppl 4): 24-32
3. Bokemeyer C, Kollmannsberger C, Meisner C, Harstrick A, Beyer J, Metzner B, Hartmann JT, Schmoll HJ, Einhorn L, Kanz L, Nichols C (1999) First-line high-dose chemotherapy compared with standard-dose PEB/VIP chemotherapy in patients with advanced germ cell tumors: a multivariate and matched-pair analysis. J Clin Oncol 17: 3450-3456
4. Bokemeyer C, Nichols CR, Droz JP, Schmoll HJ, Horwich A, Gerl A, Fossa SD, Beyer J, Pont J, Kanz L, Einhorn L, Hartmann JT (2002) Extragonadal germ cell tumors of the mediastinum and retroperitoneum - results from an international analysis. J Clin Oncol 20: 1864-1873
5. Bosl GJ, Motzer RJ (1997) Medical progress: testicular germ-cell cancer. N Engl J Med 337: 242-253
6. Bukowski RM, Wolf M, Kulander BG, Montie J, Crawford ED, Blumenstein B (1993) Alternating combination chemotherapy in patients with extragonadal germ cell tumours. A Southwest oncology group study. Cancer 71: 2631-2638
7. Childs WJ, Goldstraw P, Nicholls JE, Dearnaley DP, Horwich A (1993) Primary malignant mediastinal germ cell tumors: improved prognosis with platinum-based chemotherapy and surgery. Br J Cancer 67: 1098-1101
8. Collins DH, Pugh RCB (1964) Classification and frequency of testicular cancer. Br J Urol 36(Suppl 1): 1-11
9. Delgado FG, Tjulandin SA, Garin AM (1993) Long term results of treatment in patients with extragonadal germ cell tumors. Eur J Cancer 29A: 1002-1005
10. Dulmet EM, Macchiarini P, Suc B, Verley JM (1993) Germ cell tumors of the mediastinum. A 30-year experience. Cancer 72: 1894-1901
11. Ganjoó KN, Rieger KM, Kesler KA, Sharma M, Heilman DK, Einhorn LH (2000) Results of modern therapy for patients with mediastinal nonseminomatous germ cell tumors. Cancer 88: 1051-1056
12. Garnick MB, Canellos GP, Richie JP (1983) Treatment and surgical staging of testicular and primary extragonadal germ cell cancer. 250: 1733-1741
13. Harding MJ, Paul J, Gillis CR, Kaye SB (1993) Management of malignant teratoma: does referral to a specialist unit matter? Lancet 341: 999-1002
14. Hartmann JT, Einhorn L, Nichols CR, Droz JP, Horwich A, Gerl A, Fossa SD, Beyer J, Pont J, Schmoll HJ, Kanz L, Bokemeyer C (2001a) Second-line chemotherapy in patients with relapsed extragonadal nonseminomatous germ cell tumors: results of an international multicenter analysis. J Clin Oncol 19: 1641-1648
15. Hartmann JT, Fossa SD, Nichols CR, Droz JP, Horwich A, Gerl A, Beyer J, Pont J, Fizazi K, Hecker H, Kanz L, Einhorn L, Bokemeyer C (2001b) The incidence of metachronous testicular cancer in patients with extragonadal germ cell tumors. J Natl Cancer Inst 93: 1733-1738
16. Hartmann JT, Kanz L, Bokemeyer C (1999) Diagnosis and treatment of testicular cancer. Drugs 58: 257-281
17. Hartmann JT, Nichols CR, Droz JP, Horwich A, Gerl A, Fossa SD, Beyer J, Pont J, Einhorn L, Kanz L, Bokemeyer C (2000a) The relative risk of secondary non-germinal malignancies in patients with extragonadal germ cell tumors. Cancer 88: 2629-2635
18. Hartmann JT, Nichols CR, Droz JP, Horwich A, Gerl A, Fossa SD, Beyer J, Pont J, Fizazi K, Einhorn L, Kanz L, Bokemeyer C (2000b) Hematologic disorders associated with primary mediastinal nonseminomatous germ cell tumors. J Natl Cancer Inst 92: 54-61
19. Hartmann JT, Nichols CR, Droz JP, Horwich A, Gerl A, Fossa SD, Beyer J, Pont J, Kanz L, Einhorn L, Bokemeyer C (2002) Prognostic variables for response and outcome in patients with extragonadal germ cell tumors. Ann Oncol 7: 1017-1028
20. Hartmann JT, Schleucher N, Metzner B, Koehne C, Gerl A, Schleicher J, Rick O, Derigs H, Beyer J, Boehlke I, Kanz L, Bokemeyer C (2001c) Phase I/II study of sequential high dose VIP plus paclitaxel supported by PBSC in patients with 'poor prognosis' germ cell tumor (GCT). Proc Am Soc Clin Oncol 20: 173a
21. Hartmann JT, Schmoll HJ, Kuczyk MA, Candelaria M, Bokemeyer C. (1997) Postchemotherapy resections of residual masses from metastatic non-seminomatous testicular germ cell tumors. Ann Oncol 8: 531-538
22. Hidalgo M, Paz-Ares L, Rivera F, Lianes P, Huidobro G, Ruiz A, Lopez-Brea M, Sanz-Ortiz J, Lopez Lopez J, Cortes-Funes H, Tabernero JM (1997) Mediastinal non-seminomatous germ cell tumors (MNSGCT) treated with cisplatin-based combination chemotherapy. Ann Oncol 8: 555-559
23. International Germ Cell Consensus Classification (1997) A prognostic factor-erased staging system for metastatic germ cell cancers. J Clin Oncol 15: 594-603
24. Josefsen D, Ous S, Hoie J, Stenwig AE, Fossa SD (1993) Salvage treatment in male patients with germ cell tumors. Br J Cancer 67: 568-572
25. Kaplan EL, Meier P (1958) Non-parametric estimation from incomplete observation. J Am Stat Assoc 53: 457-481
26. Kay PH, Wells FC, Goldstraw P (1987) A multidisciplinary approach to primary nonseminomatous germ cell tumors of the mediastinum. Ann Thorac Surg 44: 578-582
27. Loehrer Sr PJ, Gonin R, Nichols CR, Weathers T, Einhorn LH (1998) Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor. J Clin Oncol 16: 2500-2504
28. Logothetis CJ, Samuels ML, Selig DE, Dexeus FH, Johnson DE, Swanson DA, von Eschenbach AC (1985) Chemotherapy of extragonadal germ cell tumors. J Clin Oncol 3: 316-325
29. Motzer RJ, Mazumdar M, Bajorin DF, Bosl GJ, Lyn P, Vlamis V (1997) High-dose carboplatin, etoposide, and cyclophosphamide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors. J Clin Oncol 15: 2546-2552
30. Motzer RJ, Mazumdar M, Bosl GJ, Bajorin DF, Amsterdam A, Vlamis V (1996) High-dose carboplatin, etoposide, and cyclophosphamide for patients with refractory germ cell tumors: treatment results and prognostic factors for survival and toxicity. J Clin Oncol 14: 1098-1105
31. Motzer RJ, Mazumdar M, Gulati SC, Bajorin DF, Lyn P, Vlamis V, Bosl GJ (1993) Phase II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation in first-line therapy for patients with poor-risk germ cell tumors. J Natl Cancer Inst 85: 1828-1835
32. Nichols CR, Heerema NA, Palmer C, Loehrer Sr PJ, Williams SD, Einhorn LH (1987) Klinefelter's syndrome associated with mediastinal germ cell neoplasms. J Clin Oncol 5: 1290-1294
33. Nichols CR, Hoffman R, Einhorn LH, Williams SD, Wheeler LA, Garnick MB (1985) Hematologic malignancies associated with primary mediastinal germ-cell tumors. Ann Intern Med 102: 603-609
34. Nichols CR, Roth BJ, Heerema N, Griep J, Tricot G (1990a) Hematologic neoplasia associated with primary mediastinal germ cell tumors. N Engl J Med 322: 1425-1429
35. Nichols CR, Saxman S, Williams SD, Loehrer PJ, Miller ME, Wright C, Einhorn LH (1990b) Primary mediastinal nonseminomatous germ cell tumors: a modern single institution experience. Cancer 65: 1641-1646
36. Nichols CR, Williams SD, Loehrer PJ, Greco FA, Crawford ED, Weetlaufer J, Miller ME, Bartolucci A, Schacter L, Einhorn LH (1991) Randomized study of cisplatin dose intensity in poor-risk germ cell tumors: a Southeastern Cancer Study Group and Southwest Oncology Group protocol. J Clin Oncol 7: 1163-1172
37. Rick O, Bokemeyer C, Beyer J, Hartmann JT, Schwella N, Kingreen D, Neureither S, Metzner B, Casper J, Wandt H, Hartmann F, Schmoll HJ, Derigs G, Gerl A, Berdel WE, Kanz L, Siegert W (2001) Salvage treatment with paclitaxel, ifosfamide, and cisplatin plus high-dose carboplatin, etoposide, and thiotepa followed by autologous stem-cell rescue in patients with relapsed or refractory germ cell cancer. J Clin Oncol 19: 81-88
38. Saxman SB, Nichols CR, Einhorn LH (1994) Salvage chemotherapy in patients with extragonadal nonseminomatous germ cell tumors: The Indiana University experience. J Clin Oncol 12: 1390-1393
39. Toner GC, Geller NL, Lin SY, Bosl GJ (1991) Extragonadal and poor risk nonseminomatous germ cell tumors. Survival and prognostic features. Cancer 67: 2049-2057
40. Ulbright TM, Loehrer PJ, Roth LM, Einhorn LH, Williams SD, Clark SA (1984) The development of non-germ cell malignancies within germ cell tumors, a clinicopathologic study of 11 cases. Cancer 54: 1824-1833
41. Vuky J, Bains M, Bacik J, Higgins G, Bajorin DF, Mazumdar M, Bosl GJ, Motzer RJ (2001) Role of postchemotherapy adjunctive surgery in the management of patients with nonseminoma arising from the mediastinum. J Clin Oncol 19: 682-688
42. Wright CD, Kesler KA, Nichols CR, Mahomed Y, Einhorn LH, Miller ME, Brown JW (1990) Primary mediastinal nonseminomatous germ cell tumors. Results of a multimodality approach. J Thorac Cardiovasc Surg 99: 210-217